Aldactone Tablet, Film Coated
Product Images NDC 0025-1041

7 FDA label images from Pfizer Laboratories Div Pfizer Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Aldactone (NDC 0025-1041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Aldactone 01)

Chemical Structure (Aldactone 01)
Chemical structure of spironolactone, the active ingredient in Aldactone tablets. The diagram depicts the molecular arrangement including rings and functional groups characteristic of spironolactone's steroidal framework.*
FDA Label Image

Figure 1 (Aldactone 02)

Figure 1 (Aldactone 02)
A survival probability curve comparing spironolactone and placebo over time in months. The y-axis represents probability, ranging from 0 to 1, and the x-axis represents months up to 48. The graph shows two lines indicating different survival probabilities for groups of patients (spironolactone n=822 and placebo n=841), with a log-rank p-value less than 0.001.*
FDA Label Image

Figure 2 (Aldactone 03)

Figure 2 (Aldactone 03)
A forest plot chart displaying hazard ratios (HR) and 95% confidence intervals for various subgroups of patients treated with spironolactone versus placebo. Subgroups include age, sex, race, LVEF percentage, heart failure type, NYHA classification, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin, ACE inhibitor, and beta blocker use. The chart visualizes comparative effectiveness across these categories.*
FDA Label Image

Logo (Aldactone 04)

FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Principal Display Panel (25 mg Tablet Bottle Label)
The label is for Aldactone 25 mg film-coated tablets, containing the active ingredient spironolactone. The product is distributed by Pfizer Laboratories Div Pfizer Inc and made in Great Britain. The label indicates 100 tablets per container and includes storage instructions to keep below 77°F (25°C) and protect from light. It is marked Rx only and includes barcode and lot/expiration area.*
FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Principal Display Panel (50 mg Tablet Bottle Label)
Aldactone 50 mg film-coated tablets label showing the product name, generic name spironolactone, strength 50 mg, and package size of 100 tablets. The label indicates it is a prescription drug (Rx only) distributed by Pfizer Laboratories, with storage instructions to keep below 77°F (25°C) and protect from light. The label includes barcode and NDC 0025-1041-31, with manufacturing location stated as Great Britain.*
FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
Aldactone 100 mg film-coated tablets, USP, by Pfizer Laboratories Div Pfizer Inc. The label includes dosage and use instructions noting each tablet contains 100 mg spironolactone, storage directions to keep below 77°F and protect from light, and dispensing in child-resistant containers. The package contains 100 tablets and is marked Rx only. The product is distributed by Pfizer Labs, made in Great Britain, and displays a barcode and NDC 0025-1031-31.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.